SLS-009
/ Seelos Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 05, 2023
Seelos Therapeutics to Present a Poster on SLS-009 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting
(PRNewswire)
- "Seelos is also evaluating SLS-009 in two preclinical in vivo studies in Amyotrophic Lateral Sclerosis and Alzheimer's Disease...Seelos Therapeutics, Inc...announced that it has been selected to present a poster on SLS-009 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting, to be held on May 16-20, 2023, in Los Angeles, California."
Preclinical • Alzheimer's Disease • Amyotrophic Lateral Sclerosis • CNS Disorders
1 to 1
Of
1
Go to page
1